Medtrade Products Ltd

Medtrade Products Ltd is a United Kingdom-based medical technology company headquartered in Crewe. It is known globally for developing patented haemostatic technologies and advanced wound care products, most notably under the CELOX™ brand. The company operates across pre-hospital, hospital, military, emergency medical services, workplace, long-term care and personal-use markets, and manages the full product development cycle from research and development through manufacturing, regulatory approval, clinical evaluation and commercialisation. Medtrade has been established in the UK for over 25 years. Its flagship CELOX™ technology is a proprietary haemostatic platform used in products such as CELOX™ Rapid Gauze, CELOX™ Granules and CELOX™ PPH, designed to stop bleeding quickly in challenging trauma and emergency situations. Beyond haemorrhage control, the company offers advanced wound care dressings for acute and chronic wounds, infection prevention solutions, respiration management products and burn treatment products. In February 2025, Medtrade Products announced it would rebrand and trade as CELOX Medical, unifying its identity under the globally recognised CELOX name. The company continues to invest in CELOX™ technology and other pioneering medical solutions. It describes itself as a global med-tech company dedicated to saving and improving lives by stopping bleeding and supporting the healing of traumatic and chronic wounds through continual product innovation using patented and evidence-based technologies. Medtrade's product portfolio includes CELOX™ Rapid, CELOX™-A, CELOX™ Granules, CELOX™ Gauze, MAG-TQ™, FOXSEAL™, FOXSEAL™ Vented, Silvapro, and the AVARUS™ advanced wound care range (IV, Multiflex, Border Foam, Post Op). The company serves distribution partners worldwide and positions itself as offering full-service support across the product lifecycle.

Medtrade Products Ltd has been established in the United Kingdom for over 25 years, with its headquarters in Crewe. The company built its reputation on the development of advanced haemostatic and wound care solutions, particularly through its patented CELOX™ technology. CELOX™ is a proprietary haemostatic platform used in products designed to stop bleeding rapidly in emergency, trauma and military settings. Over the years, Medtrade expanded its portfolio beyond haemorrhage control into advanced wound care, infection prevention, respiration management and burn treatment. Its products, including CELOX™ Rapid Gauze, CELOX™ Granules and CELOX™ PPH, gained global recognition. The company manages the entire product development cycle, from research and development through advanced manufacturing, regulatory affairs, clinical evaluation and marketing, supporting distribution partners worldwide. In February 2025, Medtrade Products announced a rebranding to CELOX Medical. The decision aligned with the company's strategic vision of unifying its identity under the globally renowned CELOX name and focusing on providing innovative life-saving products for emergency, trauma and advanced wound care worldwide. The company continues to invest in CELOX™ technology and other pioneering medical solutions under the CELOX Medical name. Medtrade has received recognition for its growth and innovation, including being named UK’s Most Ambitious Business Leader 2024 (Russ Mably), winning the Scale-Up Entrepreneur of the Year Award 2023, and receiving the Innovation of the Year 2023 award. In September 2024, the company celebrated 25 years of excellence.

• Medtrade Products announces rebranding to CELOX Medical.

• Russ Mably named as UK’s Most Ambitious Business Leader 2024.

• Celebrating 25 Years of Excellence.

• Medtrade Wins Scale-Up Entrepreneur of the Year Award 2023.

• Medtrade awarded Innovation of the Year 2023.

Global med-tech company dedicated to saving and improving lives by stopping bleeding and supporting the healing of traumatic and chronic wounds through continual product innovation using patented and evidence-based technologies.

• CELOX™ Rapid

  Haemostatic product for rapid bleeding control.

• CELOX™-A

  Haemostatic product.

• CELOX™ Granules

  Granular haemostatic agent.

• CELOX™ Gauze

  Haemostatic gauze for bleeding control.

• MAG-TQ™

  Tourniquet product.

• FOXSEAL™

  Respiration management product.

• FOXSEAL™ Vented

  Vented respiration management product.

• Silvapro

  Burn treatment product.

• AVARUS™ IV

  Advanced wound care product.

• AVARUS™ Multiflex

  Advanced wound care product.

• AVARUS™ Border Foam

  Advanced wound care product.

• AVARUS™ Post Op

  Advanced wound care product.

1. 1Home - Celox Medicalceloxmedical.com
2. 2About Us - Celox Medicalceloxmedical.com
3. 3Medtrade Products announces rebranding to CELOX Medicalceloxmedical.com
4. 4Medtrade (United Kingdom) - Wikidatawikidata.org